Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.National Medicine and Poison Board (NMPB) Republic of Sudan has granted good manufacturing practices (GMP) accreditation to seven facilities of Venus Remedies situated at its Baddi plant in Himachal Pradesh, India.
Subscribe to our email newsletter
Venus Remedies said that in the seven accredited facilities the company produces drugs for oncology lyophilized, cardiovascular, oncology liquid, carbapenem, small volume infusion and other speciality injection.
Venus Remedies has already submitted 17 critical care products and is now planning to get registration for the products manufactured in all the seven facilities.
Manu Chaudhary, joint managing director of Venus Remedies, said: “Venus is now looking forward to serve Sudan, which is the largest country in Africa. MENA (Middle East and North Africa) region is believed to be one of the most stringent regulatory approval systems across the globe.”
Venus Remedies India is a research and development driven, pharmaceutical manufacturing company. Venus Remedies has two manufacturing locations in India and Germany.
Venus Remedies manufacturers oncological and cefelosporine injectable products following EU-GMP norms for all is activities.